Babson Diagnostics featured in Capital City Innovation Annual Report
March 11, 2019
Austin, Texas, March 11, 2019 — Babson Diagnostics, Inc., a healthcare technology company focused on moving laboratory testing to the pharmacy counter, was featured today in Capital City Innovation's 2018 Annual Review. Capital City Innovation is a 501(c)(3) nonprofit focused on cultivating collaboration and growth in Austin's Innovation District, the thriving downtown area that includes UT Austin and Dell Seton Medical Center. In its annual review, Capital City Innovation celebrated Babson Diagnostics as the first graduate of WorkSpaces @ Texas Health CoLab, an Innovation District incubator at UT Austin's Dell Medical School. This graduation is not only a success for the Babson Diagnostics team, who are now moving into their first clinical laboratory, but also for WorkSpaces and the Innovation District as a whole—a signal that healthcare innovation in Austin is flourishing.
The Capital City Innovation annual report is available at: capitalcityinnovation.org/Austin-innovation-district-annual-review-2018.pdf.
About Babson Diagnostics
Babson Diagnostics is a healthcare technology company focused on moving laboratory testing to the pharmacy counter. Babson has developed a model for diagnostic blood testing that maintains a high standard of accuracy, yet requires only one-tenth the sample size of traditional venipuncture methods.